Here are relevant reports on : molecular-modeling-software-market
-
Blood Culture Tests Market by Method (Conventional, Automated), Product (Consumables, Instruments), Technology (Culture, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospitals, Reference Labs) & Region- Global Forecast to 2028
The global blood culture tests market, valued at US$4.5 billion in 2021, stood at US$5.2 billion in 2023 and is projected to advance at a resilient CAGR of 8.0% from 2023 to 2028, culminating in a forecasted valuation of US$7.6 billion by the end of the period. Growth in this market is majorly driven by the factors such as the growing incidence of sepsis cases and high cost treatment, rising geriatric population, high incidence of bloodstream infections, growing demand for rapid diagnostic techniques and high prevalence of infectious diseases.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Molecular Breeding Market by Process (QTL Mapping, Marker-Assisted Selection, Marker-Assisted Backcrossing, and Genomic Selection), Marker (SNP, SSR), Application (Crop Breeding and Livestock Breeding), and Region-Global Forecast to 2023
The molecular breeding market is estimated at USD 1.79 billion in 2018 and is projected to reach USD 3.95 billion by 2023, at a CAGR of 17.11% during the forecast period. The agricultural benefits associated with these adjuvant solutions are the major factors contributing to the growth of this market, globally. The growth of economies in developing countries, coupled with the increasing R&D expenses in the agriculture industry drives the growth potential of these markets.The global market for molecular breeding is dominated by key players such as Eurofins (Luxembourg), Illumina (US), LGC Limited (UK), Thermo Fisher Scientific (US), and SGS (Switzerland). Some emerging players in the molecular breeding market include DanBred (Denmark), Intertek Group (UK), LemnaTec (Germany), Charles River (US), Slipstream Automation (New Zealand), and Fruitbreedomics (consortium).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Nanosensors Market - By Application, Technology (Carbon nanotube, Nanowires) ,TYPES (Gas/Liquid, Bio-molecular), & Geography - Analysis & Forecast (2014-2020)
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Malaria Diagnostics Market by Technology (Microscopy, Rapid Diagnostic Tests, Molecular Diagnostic Tests), End User (Hospitals, Clinics, Diagnostics Centers, and Others), and Geography - Global Forecast to 2027
The global malaria diagnostics market size is projected to reach USD 1.02 Billion by 2027 from USD 770.5 million in 2022, at a CAGR of 5.4% during the forecast period. Market is driven by factors such as rise in the prevalence of malaria in developing countries. Moreover, the surge in awareness initiatives by governments and the increase in research for new malaria diagnostics are the factors that boost the growth of this market. However, lack of alertness about healthcare in developing countries is a major factor that restricts the malaria diagnostics market growth.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Zika Virus Testing Market by Technology, (Molecular Test (Polymerase Chain Reaction, Nucleic Acid Amplification Testing), Serology Test (Elisa, Prnt), End User (Diagnostic Laboratory, Hospital, Clinics, Academic Institutes) - Global Forecast to 2023
The Zika virus is a mosquito-borne flavivirus that was initially discovered in Uganda’s Zika forest in 1947. Before 2015, outbreaks of Zika virus infection had been restricted to some parts of Africa, Asia, and the South Pacific. In early 2015, a widespread outbreak of Zika fever, caused by the Zika virus detected in Brazil and subsequently spread to other parts of South and North America. Due to this, a number of countries issued travel warnings, and the outbreak will result in restricts tourism significantly. Furthermore, the outbreak raised concerns regarding the safety of athletes and viewers at the 2016 Summer Olympics in Rio de Janeiro. This sudden outbreaks resulted in increased demand for Zika virus testing.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Hygroscopic Building Material Market by Adsorption Process, End Use, Type (Inorganic Minerals, Inorganic Salts, Natural Materials, Molecular Sieve, Silica/Silicon Dioxide), Application (Building Material, Structural) and Region - Global Forecast to 2027
The global hygroscopic building material market is expected to grow from USD 818 million in 2022 to USD 1,120 million by 2027, at a compound annual growth rate (CAGR) of 6.5% during the forecast period.The key players Porocel Corporation (US), W.R. Grace (US), Clariant (Switzerland), BASF SE (Germany), Arkema SA (France), Honeywell International (UK), Jalon Chemicals (China), Hengye Inc (US), Dessica Chemicals (India), and Fuji Silysia Chemical Ltd. (Japan).
- Published: April 2022
- Price: $ 4950
- TOC Available:
-
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries. The neuroscience antibodies and assays market is fragmented, with the presence of several large as well as emerging players. Some of the the top players in this market are Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Plant Genomics Market by Objective (Extraction, Sequencing, Genotyping, Gene Expression, MAS, and GMO-trait Purity Testing), Type (Molecular Engineering and Genetic Engineering), Trait, Application, and Region - Global Forecast 2025
The Plant Genomics Market is expected to grow from USD 7.3 billion in 2019 to USD 11.7 billion by 2025, at a CAGR of 8.3% during the forecast period. This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the plant genomics market. It includes the profiles of leading companies such as Eurofins Scientific (Luxembourg), Illumina, Inc. (US), NRGene (Israel), Neogen Corporation (US), Qiagen (Germany), Agilent Technologies (US), KeyGene (Netherlands), LC Sciences (US), Traitgenetics GmbH (Germany), Novogene Corporation (China), Oxford Nanopore Technologies (UK), Genewiz (US), BGI Genomics (China), Genotypic Technologies (India), and Floragenex (US).
- Published: August 2019
- Price: $ 4950
- TOC Available:
-
Targeted Protein Degradation Market by Type [PROTACs (Vepdegestrant, Bavdegalutamide), SERDs (Elacestrant), Molecular Glues (Mezigdomide), LDD, LYTAC/ATAC], Indication (Oncology, Inflammatory), Formulation (Oral), End User - Global Forecast to 2035
The global targeted protein degradation market, valued at US$0.01 billion in 2024, stood at US$0.48 billion in 2025 and is projected to advance at a resilient CAGR of 35.4% from 2025 to 2035, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The Asia Pacific market is projected to grow at a significant CAGR during the forecast period, owing to increasing research & development activities for novel degraders.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Influenza Diagnostics Market by Product (Test Kits, Instruments), Test Type (Traditional (RIDT, Viral Culture, Serological), Molecular (PCR, INAAT- NASBAT, TMABAS)), End User (Diagnostic Laboratories, Hospitals, Clinics) & Region - Global Forecast to 2026
The global influenza diagnostics market growth is primed to transition from $0.8 billion in 2021 to $1.1 billion by 2026, showcasing a strong CAGR of 7.7%. Key factors driving this growth include increasing demand for rapid disease diagnosis, rising influenza prevalence, and advancements in diagnostic technologies.
- Published: September 2021
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
